Shanghai, China

Huijuan Song

This inventor holds 10 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Novartis Ag, University of Pennsylvania. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huijuan Song. Retrieved from https://idiyas.com/inventor/huijuan-song

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 100.0


 

Average Co-Inventor Count = 9.3

ph-index = 4

Forward Citations = 111(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Huijuan Song: Pioneering Innovator in Immunotherapy

Introduction

Huijuan Song is an accomplished inventor based in Shanghai, China, known for her significant contributions to the field of immunotherapy. With a remarkable nine patents to her name, she continues to push the boundaries of medical science and innovation.

Latest Patents

Among her latest patents are groundbreaking inventions focused on human mesothelin chimeric antigen receptors. These innovations encompass compositions and methods for treating diseases associated with mesothelin expression. Specifically, her patents include the development of chimeric antigen receptors (CAR) specific to mesothelin, which are crucial for creating vectors and recombinant T cells that express these receptors. Additionally, she has pioneered methods for administering genetically modified T cells featuring a CAR with a mesothelin binding domain.

Furthermore, another of her notable inventions involves targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy. This invention outlines compositions and methods designed to enhance the specificity and activity of immune effector cells, which are vital for effective immunotherapy. One embodiment details a specialized type of chimeric antigen receptor (referred to as 'NKR-CAR'), incorporating elements from natural killer (NK) cells and their receptors.

Career Highlights

Throughout her career, Huijuan Song has honed her expertise while working with leading organizations such as Novartis AG and the University of Pennsylvania. Her dedication to research and innovation has positioned her as a key figure in her field, earning her respect among peers and industry leaders alike.

Collaborations

In her quest for innovation, Huijuan has collaborated with several esteemed professionals, including Qilong Wu and Boris Engels. These partnerships have facilitated the exchange of ideas and expertise, further enhancing her research and development efforts.

Conclusion

Huijuan Song's contributions to immunotherapy and her impressive portfolio of patents showcase her prowess as an inventor. Her ongoing work in developing chimeric antigen receptors and methods for enhancing immune responses holds the potential to revolutionize treatments for various diseases. As Huijuan continues her journey, her innovative spirit and collaborations will undoubtedly pave the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…